Healthcare -
Biotechnology - NASDAQ - US
$ 4.975
-2.26 %
$ 216 M
Market Cap
-2.43
P/E
ABEO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ABEO - Abeona Therapeutics Inc.
37.1 M
LAST VALUE
22.09%
2 YEAR CAGR
46.58%
5 YEAR CAGR
104.48%
10 YEAR CAGR